4 Results for "

IRAK4-IN-5

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "IRAK4-IN-5" in MCE Product Catalog:

Cat. No.: HY-122707
CAS No.: 509093-72-5
Research Areas:  

Inflammation/Immunology

IRAK4-IN-5 is an interleukin-1 receptor-associated kinase 4 (IRAK-4) inhibitor with a Ki value of 2.8 nM. IRAK4-IN-5 interacts with non-conserved residues of IRAK-4, thereby conferring selectivity over related kinases. IRAK4-IN-5 can be used in the research of inflammatory lesions (atherosclerosis, arthritis) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-146244
CAS No.: 525625-52-9
Purity:  98.32%
Synonyms: ODN 2006; PF-3512676; CpG 7909; ODN 7909
Agatolimod ((ODN 2006; PF-3512676; CpG 7909)) is a TLR9 agonist and immunomodulator with an EC50 of 180 nM against human TLR9. Agatolimod activates and upregulates the expression of both TLR9 and TLR6, and mediates downstream signaling pathways via IRAK4, IRF5, IRF7. Agatolimod induces Th1-type innate and adaptive immune responses, activates various immune cells and promotes antigen presentation, regulates antibody levels and immune cell infiltration, upregulates the secretion of multiple cytokines, induces apoptosis and cell cycle arrest, enhances cytotoxicity, and clears intracellular Salmonella. Agatolimod is applicable to research on COVID-19, breast cancer, lung adenocarcinoma, HPV-related tumors, melanoma, and salmonellosis .
loading...
    loading...
Cat. No.: HY-139316
CAS No.: 2360530-61-4
Target:  

IRAK PROTACs

Research Areas:  

Cancer

PROTAC IRAK4 degrader-5 is a Cereblon-based IRAK4 degrader extracted from patent US20190192668A1, compound I-171 .
loading...
    loading...
Cat. No.: HY-168311
CAS No.: 2654056-24-1
Research Areas:  

Cancer

PROTAC IRAK4 ligand-5 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). PROTAC IRAK4 ligand-5 can be utilized for the synthesis of KT-413 (HY-153368) .
loading...
    loading...